-
Diagnostics World News | Illumina’s TruSight Oncology 500 HRD, a research-use-only oncology homologous recombination deficiency test, is now available in the US thanks to an expanded partnership between Illumina and Myriad Genetics. The expanded partnership also establishes a unique companion diagnostic alliance for the pharmaceutical industry, which will enable more clinical research for gene-based, targeted therapies.
Mar 8, 2023
-
Diagnostics World News | Sarah Hersey, VP of Precision Medicine at Bristol Myers Squibb, gave a balanced view of the challenges and opportunities facing precision medicine in her keynote address at the Molecular & Precision Medicine Tri-Conference in San Diego this week. After her presentation she was joined by others in the space to talk about the future for diagnostics and precision medicine.
Mar 7, 2023
-
Diagnostics World News | Researchers at University of Massachusetts, Amherst, have created bacteria-generated sensing devices capable of identifying real-time changes in various chemical concentrations.
Mar 2, 2023
-
Diagnostics World News | Growing interest in the use and utility of digital health technologies (DHTs) was on full display at the recent Summit for Clinical Ops Executives. While outsourcing professionals were learning from Merck’s experience in evaluating and selecting DHT suppliers, digital data specialists were getting a progress update on a study comparing sensor-based symptom measures with traditional clinician-rated assessments in patients with early, untreated Parkinson’s Disease.
Mar 1, 2023